

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to zinc ion (GO:0071294) | 5.02788416 |
| 2 | response to peptidoglycan (GO:0032494) | 4.77856666 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.75847702 |
| 4 | respiratory burst (GO:0045730) | 4.48439630 |
| 5 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.47093617 |
| 6 | reactive oxygen species biosynthetic process (GO:1903409) | 4.38949912 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18267295 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.18267295 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18267295 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18267295 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18267295 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.18267295 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.03422194 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00294687 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68550644 |
| 16 | cellular extravasation (GO:0045123) | 3.65814405 |
| 17 | leukocyte aggregation (GO:0070486) | 3.61782139 |
| 18 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.60472730 |
| 19 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.60472730 |
| 20 | cellular response to cadmium ion (GO:0071276) | 3.53617759 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48803547 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48803547 |
| 23 | negative regulation of cell killing (GO:0031342) | 3.48516679 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48516679 |
| 25 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.48167312 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43559898 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.41353040 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.37956243 |
| 29 | superoxide anion generation (GO:0042554) | 3.29725742 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27399957 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25678808 |
| 32 | response to host immune response (GO:0052572) | 3.25678808 |
| 33 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.25178865 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.24363474 |
| 35 | cytidine metabolic process (GO:0046087) | 3.21073817 |
| 36 | cytidine catabolic process (GO:0006216) | 3.21073817 |
| 37 | cytidine deamination (GO:0009972) | 3.21073817 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.20093529 |
| 39 | disruption of cells of other organism (GO:0044364) | 3.17571261 |
| 40 | killing of cells of other organism (GO:0031640) | 3.17571261 |
| 41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17166589 |
| 42 | positive regulation of mast cell activation (GO:0033005) | 3.15209836 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.12695269 |
| 44 | B cell mediated immunity (GO:0019724) | 3.09171443 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06712055 |
| 46 | regulation of chemokine biosynthetic process (GO:0045073) | 3.06404774 |
| 47 | response to fungus (GO:0009620) | 3.06328624 |
| 48 | granulocyte activation (GO:0036230) | 3.06166591 |
| 49 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.03101755 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02226942 |
| 51 | neutrophil activation (GO:0042119) | 3.01596842 |
| 52 | leukocyte mediated cytotoxicity (GO:0001909) | 3.01021745 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 3.00887708 |
| 54 | response to interferon-beta (GO:0035456) | 2.97916246 |
| 55 | response to host (GO:0075136) | 2.95302311 |
| 56 | response to host defenses (GO:0052200) | 2.95302311 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95302311 |
| 58 | cellular response to type I interferon (GO:0071357) | 2.94934627 |
| 59 | type I interferon signaling pathway (GO:0060337) | 2.94934627 |
| 60 | detection of other organism (GO:0098543) | 2.92401642 |
| 61 | aldehyde catabolic process (GO:0046185) | 2.91734793 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91460034 |
| 63 | T-helper 1 type immune response (GO:0042088) | 2.89139610 |
| 64 | response to type I interferon (GO:0034340) | 2.89131117 |
| 65 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.87315567 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 2.85946983 |
| 67 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.84847783 |
| 68 | regulation of mast cell activation (GO:0033003) | 2.83273684 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81443669 |
| 70 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.81424708 |
| 71 | regulation of growth of symbiont in host (GO:0044126) | 2.81424708 |
| 72 | negative regulation of growth of symbiont in host (GO:0044130) | 2.81424708 |
| 73 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.81424708 |
| 74 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.81133256 |
| 75 | cellular response to interferon-gamma (GO:0071346) | 2.81088581 |
| 76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.80689820 |
| 77 | defense response to fungus (GO:0050832) | 2.80430465 |
| 78 | neutrophil chemotaxis (GO:0030593) | 2.79627296 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.78866368 |
| 80 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.78354232 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77709193 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.77709193 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.76736344 |
| 84 | cell killing (GO:0001906) | 2.75606173 |
| 85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74007000 |
| 86 | response to interferon-gamma (GO:0034341) | 2.73357829 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.73302149 |
| 88 | neutrophil migration (GO:1990266) | 2.72122182 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.71034908 |
| 90 | microglial cell activation (GO:0001774) | 2.70696626 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70605724 |
| 92 | actin nucleation (GO:0045010) | 2.70236146 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69746529 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68979370 |
| 95 | detection of bacterium (GO:0016045) | 2.66243551 |
| 96 | response to interferon-alpha (GO:0035455) | 2.64857639 |
| 97 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.64716051 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63323217 |
| 99 | phagosome maturation (GO:0090382) | 2.62877287 |
| 100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62313725 |
| 101 | signal peptide processing (GO:0006465) | 2.61850908 |
| 102 | lymphocyte chemotaxis (GO:0048247) | 2.60655818 |
| 103 | cellular response to interferon-beta (GO:0035458) | 2.59137520 |
| 104 | angiotensin maturation (GO:0002003) | 2.58576870 |
| 105 | regulation of interleukin-1 secretion (GO:0050704) | 2.58297473 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.57609331 |
| 107 | sequestering of metal ion (GO:0051238) | 2.57518651 |
| 108 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.57241551 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56750282 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.55985965 |
| 111 | hydrogen peroxide metabolic process (GO:0042743) | 2.55876770 |
| 112 | detection of biotic stimulus (GO:0009595) | 2.55047481 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54471772 |
| 114 | granulocyte chemotaxis (GO:0071621) | 2.54178167 |
| 115 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.53193106 |
| 116 | mast cell activation (GO:0045576) | 2.52545373 |
| 117 | regulation of hypersensitivity (GO:0002883) | 2.51589928 |
| 118 | negative regulation of viral genome replication (GO:0045071) | 2.51382146 |
| 119 | natural killer cell mediated immunity (GO:0002228) | 2.51369674 |
| 120 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.51369674 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51126365 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 2.49960911 |
| 123 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49885481 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49098997 |
| 125 | positive regulation of tolerance induction (GO:0002645) | 2.48816389 |
| 126 | DNA deamination (GO:0045006) | 2.48167280 |
| 127 | granulocyte migration (GO:0097530) | 2.45661130 |
| 128 | positive regulation of interferon-beta production (GO:0032728) | 2.44302196 |
| 129 | defense response to protozoan (GO:0042832) | 2.44195433 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.43417147 |
| 131 | positive regulation of defense response to virus by host (GO:0002230) | 2.42597333 |
| 132 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.42540092 |
| 133 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.42343876 |
| 134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.41841905 |
| 135 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.41560976 |
| 136 | phospholipid efflux (GO:0033700) | 2.41502871 |
| 137 | regulation of interleukin-8 secretion (GO:2000482) | 2.41103324 |
| 138 | detection of external biotic stimulus (GO:0098581) | 2.40565494 |
| 139 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.39906395 |
| 140 | eosinophil chemotaxis (GO:0048245) | 2.39847533 |
| 141 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.38988718 |
| 142 | positive regulation of lymphocyte migration (GO:2000403) | 2.38468691 |
| 143 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.38361049 |
| 144 | cellular response to exogenous dsRNA (GO:0071360) | 2.38304331 |
| 145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.37910835 |
| 146 | positive regulation of interleukin-1 production (GO:0032732) | 2.36770510 |
| 147 | response to zinc ion (GO:0010043) | 2.36596395 |
| 148 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.35100448 |
| 149 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.34560143 |
| 150 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.31887225 |
| 151 | myeloid dendritic cell differentiation (GO:0043011) | 2.31822896 |
| 152 | regulation of lymphocyte migration (GO:2000401) | 2.31753775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.71119440 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.28047066 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.08724224 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.54586750 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14836330 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12936838 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12198646 |
| 8 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03342528 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02595277 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99633630 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92216364 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.49647433 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.47446319 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39636557 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39444429 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.34365963 |
| 17 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32065118 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.30345010 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26752120 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.24309927 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.19883869 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17092915 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.14956401 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12421135 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12315840 |
| 26 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08576554 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06436677 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02182842 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95771256 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93658195 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86376252 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76237056 |
| 33 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74768264 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73289461 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73251835 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69327780 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64251673 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59978010 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58170922 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56763545 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54078883 |
| 42 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51108280 |
| 43 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48101081 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46403876 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.46138979 |
| 46 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44863121 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43812511 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.43376646 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42387881 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41593200 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40684114 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40437756 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37195791 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35811507 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33919693 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32377299 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31581514 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30713971 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30100295 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29145216 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28339165 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28160025 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27873377 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27147735 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26983727 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23988214 |
| 67 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23449883 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20494504 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18513860 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16359721 |
| 71 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15630002 |
| 72 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13897993 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13315438 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12182350 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11992174 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11900880 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11663526 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11524667 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11505851 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09957850 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09787337 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09300235 |
| 83 | * MYB_26560356_Chip-Seq_TH1_Human | 1.07426023 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06292625 |
| 85 | MAF_26560356_Chip-Seq_TH1_Human | 1.05141702 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01484610 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98263624 |
| 88 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97789198 |
| 89 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96655340 |
| 90 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96204325 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96144106 |
| 92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.94110727 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94032061 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93841249 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93248365 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92849413 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92695858 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92577710 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91650326 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90521149 |
| 101 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.90152512 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89983674 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89519620 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89262455 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88624012 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88382296 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87682381 |
| 108 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87409074 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87379577 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87182071 |
| 111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86308224 |
| 112 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86308224 |
| 113 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.84709847 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84480615 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83940434 |
| 116 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.83354963 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83110823 |
| 118 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.83006396 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82814300 |
| 120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82814300 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82598672 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82415693 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82410853 |
| 124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82293874 |
| 125 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81442214 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81050287 |
| 127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81028196 |
| 128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.80834907 |
| 129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.80425199 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80087844 |
| 131 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80058868 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.79721479 |
| 133 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79611247 |
| 134 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79403571 |
| 135 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.77470623 |
| 136 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.77464367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.76664234 |
| 2 | MP0009785_altered_susceptibility_to | 3.58916353 |
| 3 | MP0005360_urolithiasis | 3.38267421 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.23788000 |
| 5 | MP0003724_increased_susceptibility_to | 3.04597792 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.81560252 |
| 7 | MP0002419_abnormal_innate_immunity | 2.76496880 |
| 8 | MP0009840_abnormal_foam_cell | 2.69013897 |
| 9 | MP0005025_abnormal_response_to | 2.56806402 |
| 10 | MP0003303_peritoneal_inflammation | 2.56299319 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.46462610 |
| 12 | MP0006082_CNS_inflammation | 2.43966439 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.43390005 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.42643631 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.30208445 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.09603354 |
| 17 | MP0003195_calcinosis | 2.02707351 |
| 18 | MP0005671_abnormal_response_to | 2.02277077 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.98150354 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.96536413 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.95803269 |
| 22 | MP0003011_delayed_dark_adaptation | 1.89763868 |
| 23 | MP0000343_altered_response_to | 1.88099597 |
| 24 | MP0002723_abnormal_immune_serum | 1.87205630 |
| 25 | MP0009764_decreased_sensitivity_to | 1.86936982 |
| 26 | MP0001800_abnormal_humoral_immune | 1.84210842 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.82636285 |
| 28 | MP0001790_abnormal_immune_system | 1.80991431 |
| 29 | MP0005387_immune_system_phenotype | 1.80991431 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80372484 |
| 31 | MP0008469_abnormal_protein_level | 1.79101586 |
| 32 | MP0003186_abnormal_redox_activity | 1.78022608 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.77262586 |
| 34 | MP0001819_abnormal_immune_cell | 1.76704440 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.75868891 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.74813751 |
| 37 | MP0000685_abnormal_immune_system | 1.69578436 |
| 38 | MP0001853_heart_inflammation | 1.68431288 |
| 39 | MP0004947_skin_inflammation | 1.68290057 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.65778108 |
| 41 | MP0002405_respiratory_system_inflammati | 1.55176986 |
| 42 | MP0005365_abnormal_bile_salt | 1.52545192 |
| 43 | MP0003075_altered_response_to | 1.49818271 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.48530165 |
| 45 | MP0000858_altered_metastatic_potential | 1.41598739 |
| 46 | MP0005166_decreased_susceptibility_to | 1.40351873 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.35496024 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.33560550 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.26876545 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.26119339 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.25826505 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.25826505 |
| 53 | MP0000716_abnormal_immune_system | 1.25087054 |
| 54 | MP0004510_myositis | 1.25005738 |
| 55 | MP0005451_abnormal_body_composition | 1.24974854 |
| 56 | MP0001873_stomach_inflammation | 1.24139290 |
| 57 | MP0001764_abnormal_homeostasis | 1.23986824 |
| 58 | MP0003448_altered_tumor_morphology | 1.23303171 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.23164266 |
| 60 | MP0003866_abnormal_defecation | 1.22677012 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.21859273 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.20379359 |
| 63 | MP0009278_abnormal_bone_marrow | 1.20005081 |
| 64 | MP0003646_muscle_fatigue | 1.19788307 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.18878955 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.18489395 |
| 67 | MP0000604_amyloidosis | 1.18012145 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.17464125 |
| 69 | MP0002132_abnormal_respiratory_system | 1.17296830 |
| 70 | MP0000609_abnormal_liver_physiology | 1.17018990 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.12918966 |
| 72 | MP0009763_increased_sensitivity_to | 1.11461268 |
| 73 | MP0005164_abnormal_response_to | 1.11102841 |
| 74 | MP0002398_abnormal_bone_marrow | 1.10196900 |
| 75 | MP0002933_joint_inflammation | 1.08770603 |
| 76 | MP0000490_abnormal_crypts_of | 1.08302963 |
| 77 | MP0001663_abnormal_digestive_system | 1.07214103 |
| 78 | MP0002429_abnormal_blood_cell | 1.06307968 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.06169668 |
| 80 | MP0000689_abnormal_spleen_morphology | 1.05994541 |
| 81 | MP0003279_aneurysm | 1.05430315 |
| 82 | MP0002006_tumorigenesis | 1.05104173 |
| 83 | MP0005332_abnormal_amino_acid | 1.04022768 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.02433314 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.98554418 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.98056586 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.97046845 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96589335 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.96069323 |
| 90 | MP0002722_abnormal_immune_system | 0.95234570 |
| 91 | MP0005083_abnormal_biliary_tract | 0.94950696 |
| 92 | MP0003252_abnormal_bile_duct | 0.93202729 |
| 93 | MP0004147_increased_porphyrin_level | 0.92997285 |
| 94 | MP0001542_abnormal_bone_strength | 0.92590227 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.91826101 |
| 96 | MP0002254_reproductive_system_inflammat | 0.90968306 |
| 97 | MP0005023_abnormal_wound_healing | 0.89846284 |
| 98 | MP0008260_abnormal_autophagy | 0.89497372 |
| 99 | MP0005310_abnormal_salivary_gland | 0.89040239 |
| 100 | MP0008004_abnormal_stomach_pH | 0.88893278 |
| 101 | MP0006054_spinal_hemorrhage | 0.88310459 |
| 102 | MP0003828_pulmonary_edema | 0.86556517 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.85578706 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.85194006 |
| 105 | MP0005390_skeleton_phenotype | 0.83983746 |
| 106 | MP0000249_abnormal_blood_vessel | 0.82669133 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.80802878 |
| 108 | MP0001501_abnormal_sleep_pattern | 0.79966878 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.79919299 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.79330654 |
| 111 | MP0009697_abnormal_copulation | 0.79321970 |
| 112 | MP0004883_abnormal_blood_vessel | 0.78795067 |
| 113 | MP0001851_eye_inflammation | 0.78631513 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.78495044 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.77737547 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.77138350 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.76361940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.06216053 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.55840750 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.53031615 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.25945374 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.19736865 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.98539059 |
| 7 | Myositis (HP:0100614) | 3.79727205 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.51542969 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43011178 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.32334597 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30138772 |
| 12 | Obstructive lung disease (HP:0006536) | 3.30138772 |
| 13 | Gingivitis (HP:0000230) | 3.23016571 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22806333 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.16236455 |
| 16 | Recurrent skin infections (HP:0001581) | 3.15115142 |
| 17 | Orchitis (HP:0100796) | 3.13681918 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.11645793 |
| 19 | Stomatitis (HP:0010280) | 3.06900407 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.03728550 |
| 21 | Abnormality of B cell number (HP:0010975) | 2.99704267 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 2.94667168 |
| 23 | Urticaria (HP:0001025) | 2.86160262 |
| 24 | Pustule (HP:0200039) | 2.79710973 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.71808063 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 2.71553052 |
| 27 | Nausea (HP:0002018) | 2.67367758 |
| 28 | T lymphocytopenia (HP:0005403) | 2.66777613 |
| 29 | Abnormality of T cells (HP:0002843) | 2.61859780 |
| 30 | Recurrent fungal infections (HP:0002841) | 2.61842820 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.61406710 |
| 32 | Optic neuritis (HP:0100653) | 2.61406710 |
| 33 | Neoplasm of head and neck (HP:0012288) | 2.61132335 |
| 34 | Esophageal neoplasm (HP:0100751) | 2.61132335 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.57966050 |
| 36 | Eosinophilia (HP:0001880) | 2.57668680 |
| 37 | Hemoptysis (HP:0002105) | 2.56311872 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55582693 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55582693 |
| 40 | IgG deficiency (HP:0004315) | 2.52459383 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.49841369 |
| 42 | Periodontitis (HP:0000704) | 2.49489452 |
| 43 | Joint hemorrhage (HP:0005261) | 2.47406795 |
| 44 | B lymphocytopenia (HP:0010976) | 2.47104770 |
| 45 | Chronic diarrhea (HP:0002028) | 2.44510531 |
| 46 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42848358 |
| 47 | Xanthomatosis (HP:0000991) | 2.35086635 |
| 48 | Axonal loss (HP:0003447) | 2.34517790 |
| 49 | Vasculitis (HP:0002633) | 2.32811910 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.32010939 |
| 51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.31222410 |
| 52 | Petechiae (HP:0000967) | 2.26642279 |
| 53 | Granulocytopenia (HP:0001913) | 2.25948850 |
| 54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.22942363 |
| 55 | Meningitis (HP:0001287) | 2.22288501 |
| 56 | Gingival bleeding (HP:0000225) | 2.21158653 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.20101768 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.17072093 |
| 59 | Recurrent viral infections (HP:0004429) | 2.16754004 |
| 60 | Hepatic necrosis (HP:0002605) | 2.16197007 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15110490 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13075895 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.13075895 |
| 64 | Tetraparesis (HP:0002273) | 2.12993364 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.11984012 |
| 66 | Gangrene (HP:0100758) | 2.11211412 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.10555317 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.09593836 |
| 69 | Parakeratosis (HP:0001036) | 2.08264452 |
| 70 | Prolonged partial thromboplastin time (HP:0003645) | 2.07708754 |
| 71 | Increased serum ferritin (HP:0003281) | 2.07100423 |
| 72 | Glomerulonephritis (HP:0000099) | 2.06981995 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.04747794 |
| 74 | Abnormality of eosinophils (HP:0001879) | 2.04280585 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03629483 |
| 76 | Anorexia (HP:0002039) | 2.02571354 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02540698 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.01982183 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.01528495 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.00923397 |
| 81 | Pulmonary infiltrates (HP:0002113) | 1.99976473 |
| 82 | Malnutrition (HP:0004395) | 1.99848238 |
| 83 | Increased IgM level (HP:0003496) | 1.99671706 |
| 84 | Thrombocytosis (HP:0001894) | 1.99607996 |
| 85 | Abnormality of the prostate (HP:0008775) | 1.99241377 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.98819928 |
| 87 | Basal ganglia calcification (HP:0002135) | 1.98283221 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 1.97635692 |
| 89 | Glycosuria (HP:0003076) | 1.97635692 |
| 90 | Thyroiditis (HP:0100646) | 1.97307797 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 1.96754203 |
| 92 | Mutism (HP:0002300) | 1.96223653 |
| 93 | Purpura (HP:0000979) | 1.93761630 |
| 94 | Skin rash (HP:0000988) | 1.93287333 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93007903 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93007903 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93007903 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93007901 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93007901 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93007901 |
| 101 | Cellulitis (HP:0100658) | 1.92572020 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 1.91430132 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.89983654 |
| 104 | Agammaglobulinemia (HP:0004432) | 1.89715497 |
| 105 | Pulmonary embolism (HP:0002204) | 1.89679934 |
| 106 | Encephalitis (HP:0002383) | 1.88834779 |
| 107 | Glomerulopathy (HP:0100820) | 1.88713765 |
| 108 | Prostate neoplasm (HP:0100787) | 1.88040623 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87711375 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.87285647 |
| 111 | Leukocytosis (HP:0001974) | 1.87121314 |
| 112 | Increased IgE level (HP:0003212) | 1.86612599 |
| 113 | Arterial thrombosis (HP:0004420) | 1.86392877 |
| 114 | Epistaxis (HP:0000421) | 1.86078934 |
| 115 | Loss of speech (HP:0002371) | 1.85985473 |
| 116 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85257062 |
| 117 | Joint swelling (HP:0001386) | 1.84999192 |
| 118 | Episodic fever (HP:0001954) | 1.84934293 |
| 119 | Complement deficiency (HP:0004431) | 1.84213640 |
| 120 | Recurrent pneumonia (HP:0006532) | 1.84121088 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83920367 |
| 122 | Hypoproteinemia (HP:0003075) | 1.83762955 |
| 123 | Chronic otitis media (HP:0000389) | 1.83520320 |
| 124 | IgM deficiency (HP:0002850) | 1.83130228 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 1.82850898 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.81606923 |
| 127 | Poor head control (HP:0002421) | 1.81324782 |
| 128 | Thick nail (HP:0001805) | 1.81318632 |
| 129 | Amyloidosis (HP:0011034) | 1.81266864 |
| 130 | Mitochondrial inheritance (HP:0001427) | 1.81241101 |
| 131 | Chest pain (HP:0100749) | 1.80243004 |
| 132 | Lipid accumulation in hepatocytes (HP:0006561) | 1.79951268 |
| 133 | Peritonitis (HP:0002586) | 1.79841125 |
| 134 | Polyneuropathy (HP:0001271) | 1.79713177 |
| 135 | Hypochromic anemia (HP:0001931) | 1.79408129 |
| 136 | Exertional dyspnea (HP:0002875) | 1.78962591 |
| 137 | Conjunctival hamartoma (HP:0100780) | 1.78925815 |
| 138 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77288570 |
| 139 | Abnormal platelet function (HP:0011869) | 1.77284386 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.77284386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.29104684 |
| 2 | MAP3K12 | 3.26072636 |
| 3 | ERN1 | 2.94383590 |
| 4 | RIPK4 | 2.85495042 |
| 5 | TBK1 | 2.72335477 |
| 6 | IRAK4 | 2.71168137 |
| 7 | MAP3K14 | 2.52124895 |
| 8 | TYK2 | 2.42142103 |
| 9 | TAOK3 | 2.37502727 |
| 10 | MAP4K1 | 2.33256697 |
| 11 | KIT | 2.32321150 |
| 12 | PIM2 | 2.28229256 |
| 13 | IRAK3 | 2.16994863 |
| 14 | TXK | 2.06522883 |
| 15 | NME2 | 2.02247395 |
| 16 | IKBKE | 1.90407297 |
| 17 | TEC | 1.89303905 |
| 18 | ZAP70 | 1.82301715 |
| 19 | ADRBK2 | 1.82008588 |
| 20 | JAK3 | 1.79283673 |
| 21 | MAP4K2 | 1.72826900 |
| 22 | PBK | 1.72445506 |
| 23 | TLK1 | 1.63511115 |
| 24 | MST4 | 1.63105399 |
| 25 | CSK | 1.57288002 |
| 26 | MAP3K11 | 1.52613058 |
| 27 | BTK | 1.51955452 |
| 28 | ARAF | 1.48756734 |
| 29 | NEK9 | 1.47952105 |
| 30 | GRK6 | 1.44502433 |
| 31 | IKBKB | 1.38620564 |
| 32 | FRK | 1.38484890 |
| 33 | DDR2 | 1.35744047 |
| 34 | SYK | 1.34811951 |
| 35 | EPHB1 | 1.33569532 |
| 36 | MAP2K3 | 1.31753631 |
| 37 | MYLK | 1.31555762 |
| 38 | STK16 | 1.30068405 |
| 39 | EIF2AK1 | 1.30052843 |
| 40 | BCKDK | 1.28723242 |
| 41 | MAP3K3 | 1.26801939 |
| 42 | JAK1 | 1.25227700 |
| 43 | ABL2 | 1.22506440 |
| 44 | NEK1 | 1.21828105 |
| 45 | STK10 | 1.21288876 |
| 46 | TESK1 | 1.19558144 |
| 47 | BMPR2 | 1.15253276 |
| 48 | PRKG2 | 1.14282656 |
| 49 | GRK1 | 1.07277451 |
| 50 | FGFR4 | 1.05700698 |
| 51 | LYN | 1.03487930 |
| 52 | STK24 | 1.02996506 |
| 53 | MST1R | 1.01695637 |
| 54 | BMPR1B | 0.98724768 |
| 55 | MOS | 0.97561829 |
| 56 | MAP3K5 | 0.97511067 |
| 57 | TESK2 | 0.97478414 |
| 58 | FLT3 | 0.95398359 |
| 59 | FES | 0.93893811 |
| 60 | MATK | 0.93133494 |
| 61 | HCK | 0.92249451 |
| 62 | PIK3CA | 0.91785794 |
| 63 | MUSK | 0.90430026 |
| 64 | ITK | 0.89494469 |
| 65 | PDK2 | 0.89205792 |
| 66 | PIK3CG | 0.86745998 |
| 67 | EIF2AK3 | 0.86262049 |
| 68 | PAK4 | 0.85797085 |
| 69 | GRK7 | 0.85418810 |
| 70 | LCK | 0.84504521 |
| 71 | PRKCQ | 0.84217793 |
| 72 | CSF1R | 0.83563410 |
| 73 | PRKCD | 0.83504653 |
| 74 | MAP3K13 | 0.82695394 |
| 75 | KDR | 0.81863813 |
| 76 | PIM1 | 0.80350819 |
| 77 | ADRBK1 | 0.79872922 |
| 78 | PTK2B | 0.78209857 |
| 79 | LIMK1 | 0.78181237 |
| 80 | FGR | 0.76825632 |
| 81 | JAK2 | 0.76516333 |
| 82 | TRPM7 | 0.76266459 |
| 83 | TNK2 | 0.75580502 |
| 84 | LRRK2 | 0.75352293 |
| 85 | RPS6KA4 | 0.72804163 |
| 86 | MAP3K1 | 0.72177053 |
| 87 | GRK5 | 0.70124695 |
| 88 | PDK1 | 0.68430587 |
| 89 | OXSR1 | 0.68281211 |
| 90 | NME1 | 0.66568286 |
| 91 | MAP2K2 | 0.66552597 |
| 92 | BRAF | 0.63706005 |
| 93 | MAP3K6 | 0.63149090 |
| 94 | CHUK | 0.62871080 |
| 95 | CDK19 | 0.60238600 |
| 96 | ERBB4 | 0.59101336 |
| 97 | CDK8 | 0.57011780 |
| 98 | TAOK2 | 0.56289369 |
| 99 | MAPK11 | 0.55598961 |
| 100 | BRSK2 | 0.54913197 |
| 101 | MAPK4 | 0.54663625 |
| 102 | MAPK12 | 0.54507457 |
| 103 | FGFR3 | 0.53810802 |
| 104 | NUAK1 | 0.52577860 |
| 105 | KSR2 | 0.50657718 |
| 106 | EGFR | 0.49199541 |
| 107 | ZAK | 0.48674883 |
| 108 | EIF2AK2 | 0.48543810 |
| 109 | IGF1R | 0.48128675 |
| 110 | CAMKK2 | 0.46876490 |
| 111 | TGFBR2 | 0.45407183 |
| 112 | DAPK2 | 0.45310884 |
| 113 | INSRR | 0.43205168 |
| 114 | ABL1 | 0.43201094 |
| 115 | MAPKAPK3 | 0.42353779 |
| 116 | MAP2K6 | 0.41342807 |
| 117 | FYN | 0.40967748 |
| 118 | EPHA3 | 0.39735619 |
| 119 | TAOK1 | 0.39275398 |
| 120 | MAPKAPK2 | 0.38257696 |
| 121 | PDPK1 | 0.37949772 |
| 122 | RAF1 | 0.37816027 |
| 123 | DAPK1 | 0.37408136 |
| 124 | MARK3 | 0.37359724 |
| 125 | SIK3 | 0.36002709 |
| 126 | NLK | 0.35519300 |
| 127 | ACVR1B | 0.35080859 |
| 128 | IRAK1 | 0.34847727 |
| 129 | SCYL2 | 0.34303437 |
| 130 | MAPK7 | 0.34223425 |
| 131 | MAP3K8 | 0.33809648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.23372335 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.22539770 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63087295 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.39756154 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.35346169 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09920826 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09695479 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.01429350 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96099204 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86924073 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82422893 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78855442 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.72101375 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.63317248 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62689555 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62270423 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.60662121 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.59089951 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56599373 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52876714 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52397035 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48994585 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47252910 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45328863 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44714418 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.41748546 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.41563837 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39065522 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.37414061 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37057552 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35850605 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34722466 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.34487755 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31590499 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31390555 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.31120307 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30045055 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25735586 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.24326344 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24237998 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.23452502 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22848355 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20167974 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20148886 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19365590 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17561623 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16107727 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.14369670 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13530215 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12654400 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.11764252 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10634122 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.09991077 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.05667778 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05264098 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03144335 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02718514 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00436266 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00203409 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98032033 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97382006 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96968465 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.96633278 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.95828047 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95133449 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94557999 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93646830 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91497497 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91390788 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89961628 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89375680 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85749254 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85526169 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82113418 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79063966 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76528619 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75514799 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74605741 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74467012 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74091917 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72872160 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72714804 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72380465 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71597909 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.71496972 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70825988 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70220572 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69306848 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67782237 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66627706 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66548294 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62217043 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.61592172 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61317295 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60811088 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59695368 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59564860 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58535592 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56684352 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54943345 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54535815 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.53302310 |
| 103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52977982 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52186488 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51912721 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48065045 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47919379 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47542326 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47324590 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45514212 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44477530 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43938678 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43567633 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43479729 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41514445 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30789747 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.28469637 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26392417 |

